Skip to main content

Table 1 Anthropometric data and comorbidities at baseline of the 130 patients who had been contacted at 3 months of follow-up, data is from the analysis on February 28 th 2013

From: A symptom-related monitoring program following pulmonary embolism for the early detection of CTEPH: a prospective observational registry study

Baseline data n %
Patients contacted 130  
Sex m/f 55/75 42.3%/57.7%
  Mean +/-SD
Age (years) 65.7 17.0
Height (cm) 170 9.5
Weight (kg) 82.5 17.2
BMI (kg/m2) 28.6 5.4
Comorbidities n %
Arterial hypertension 55 42.3
Coronary artery disease 11 8.5
Atrial fibrillation/flutter 19 14.6
Heart valve pathology 8 6.2
COPD 10 7.7
Asthma 8 6.2
Interstitial lung disease 6 4.6
Sleep related breathing disorder 11 8.5
Alveolar hypoventilation 1 0.8
Diabetes 15 11.5
Chronic kidney disease 9 6.9
Liver disease 6 4.6
Thyroid disorder/Struma 25 19.2
Rheumatism/collagen vascular disease 7 5.4